Interventional neuroradiology gives minimally invasive treatments for lesions of the head, neck, spine, brain, and spinal twine. Endovascular treatment options include embolotherapy, the aim of that is the occlusion of extraordinary blood vessels such as vascular malformations, aneurysms, and vascular tumors. And cerebral revascularization, the goal of that is to reopen occluded or narrowed normal vessels. Nonvascular interventions encompass ache management, percutaneous biopsies, percutaneous vertebral augmentation processes, and percutaneous management of disk disorder.
How Big is the Global Neurovascular Interventional Neurology Market?
The Global Neurovascular Interventional Neurology Market is expected to be around US$ 3.80 Billion by 2028 and will grow at a CAGR of more than 8% in the given forecast period.
The major driving factors of Global Neurovascular Interventional Neurology Market are as follows:
• Increasing target patient population
• Technical advancements in the area of interventional neurosurgeries
• Increasing healthcare infrastructure in developing nations
The restraining factors of Global Neurovascular Interventional Neurology Market are as follows:
• Ongoing healthcare developments in the U.S.
• Lack of skilled neurosurgeons
The Global Neurovascular Interventional Neurology Market is segmented on the lines of its technology, product and regional. Based on technology segmentation it covers embolization & coiling, up porting techniques, carotid artery angioplasty & stenting and neurothrombectomy. Under product segmentation it covers cerebral balloon angioplasty & stenting systems, support devices, aneurysm coiling & embolization devices and neurothrombectomy devices. The Global Neurovascular Interventional Neurology Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for neurovascular interventional neurology and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for neurovascular interventional neurology.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Neurovascular Interventional Neurology Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Stryker Corporation (U.S.), Medtronic, plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), and Penumbra, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Neurovascular Interventional Neurology Market has been segmented as below:
By Technology Analysis
• Embolization & coiling,
• Supporting techniques,
• Carotid artery angioplasty & stenting,
• Neurothrombectomy
By Product Analysis
• Cerebral balloon angioplasty & stenting systems
• Support devices
• Aneurysm coiling & embolization devices
• Neurothrombectomy devices
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Neurovascular Interventional Neurology Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Neurovascular Interventional Neurology Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Target Disease Prevalence
2.2.2 Rising Geriatric Population
2.2.3 Number of Hospitals and Surgical Centers
2.2.4 Healthcare Expenditure
2.2.5 Number of Clinical Researches
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Neurovascular Devices/Interventional Neurology Market Overview
4.2 Global Neurovascular Devices/Interventional Neurology Product Market, By Region (2022 vs 2027)
4.3 Global Neurovascular Devices/Interventional Neurology Product Market (2022 vs 2027)
4.4 Global Neurovascular Devices/Interventional Neurology Market, By Disease Pathology, By Region (2022-2027)
4.5 Neurovascular Devices/Interventional Neurology Market, By Country (2022 vs 2027)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Large Target Patient Population
5.2.1.2 Ongoing Product Development and Commercialization
5.2.1.3 Favorable Medical Reimbursements
5.2.1.4 Expansion of Healthcare Infrastructure Across Emerging Markets
5.2.1.5 Growing Market Demand for Effective Neurovascular Devices
5.2.2 Key Market Restraints
5.2.2.1 Stringent Regulatory Scenario
5.2.2.2 Dearth of Skilled Neurosurgeons
5.2.3 Key Market Opportunities
5.2.3.1 Increasing Number of Research Activities in the Field of Neurovascular Therapies
5.2.3.2 Rising Demand for Minimally Invasive Neurosurgical Procedures
5.3 Ongoing Clinical Studies
5.3.1 Embolization Coiling Procedures
5.3.2 Carotid Artery Stenting Procedures
5.3.3 Embolic Protection Procedures
5.3.4 Flow Diversion Procedures
5.3.5 Supporting Techniques
5.3.6 Neurothrombectomy Procedures
6 Industry Insights
6.1 Introduction
6.2 Supply Chain Analysis
6.3 Porter’s Five Forces Analysis
6.4 Industry Trends
6.4.1 Increasing Surgeon’s Awareness Related to Benefits of Stereotactic Framework Procedures in Neurosurgeries
6.4.2 Channel Optimization
7 Neurovascular Devices/Interventional Neurology Market, By Product
7.1 Introduction
7.2 Aneurysm Coiling & Embolization Devices
7.2.1 Embolic Coils
7.2.1.1 Bare Detachable Coils
7.2.1.2 Coated Detachable Coils
7.2.2 Flow Diversion Devices
7.2.3 Liquid Embolic Agents
7.3 Cerebral Balloon Angioplasty and Stenting Systems
7.3.1 Carotid Artery Stents
7.3.2 Embolic Protection Systems
7.3.2.1 Distal Filter Devices
7.3.2.2 Balloon Occlusion Devices
7.4 Support Devices
7.4.1 Microcatheters
7.4.2 Microguidewires
7.5 Neurothrombectomy Devices
7.5.1 Clot Retrieval Devices
7.5.2 Suction and Aspiration Devices
7.5.3 Snares
8 Global Neurovascular Devices/Interventional Neurology Market, By Disease Pathology
8.1 Introduction
8.2 Ischemic Strokes
8.3 Cerebral Aneurysms
8.4 Arteriovenous Malformation and Fistulas
8.5 Other Disease Pathologies
9 Neurovascular Devices/Interventional Neurology Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.4 Recent Developments
10.4.1 Product Launches
10.4.2 Strategic Acquisitions
10.4.3 Expansions
10.4.4 Agreements and Collaborations
10.4.5 Other Developments
11 Company Profiles
11.1 Introduction
11.1.1 Geographic Benchmarking
11.2 Stryker Corporation
11.3 Medtronic PLC
11.4 Johnson & Johnson
11.5 Terumo Corporation
11.6 Penumbra, Inc.
11.7 Boston Scientific Corporation
11.8 Microport Scientific Corporation
11.9 Merit Medical Systems, Inc.
11.10 W.L. Gore & Associates, Inc.
11.11 Abbott Laboratories
The Global Neurovascular Interventional Neurology Market has been segmented as below:
By Technology Analysis
• Embolization & coiling,
• Supporting techniques,
• Carotid artery angioplasty & stenting,
• Neurothrombectomy
By Product Analysis
• Cerebral balloon angioplasty & stenting systems
• Support devices
• Aneurysm coiling & embolization devices
• Neurothrombectomy devices
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
